Improving telehealth access for low-income patients with diabetes
Official title: Achieving Chronic Care equiTy by leVeraging the Telehealth Ecosystem
Run by University of California, San Francisco · NCT06598436 · Data updated 2026-11-12
This study is testing a new way to help low-income patients with diabetes use telehealth services better by providing coaching and support to both patients and clinics.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | University of California, San Francisco Academic / other |
| Locations | 1 site (San Francisco, California) |
| Status | Recruiting |
| Started | November 4, 2024 |
| Main results expected | September 2028 |
| Study ends | September 2028 |
| Registry record updated | January 6, 2026 |
| Trial ID | NCT06598436 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who speak English or Spanish, have diabetes with an A1C level of 8.0% or higher, and have visited a participating primary care site recently.
✕Probably not a fit
Patients with high digital literacy or severe co-morbid conditions that hinder telehealth management may not benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study examines a multi-level intervention designed to enhance telehealth access for low-income patients managing chronic conditions like diabetes and hypertension. It combines patient-level digital health coaching with clinic-level practice facilitation to address barriers to telehealth use. The intervention aims to improve digital literacy and patient engagement with virtual care, while also empowering primary care clinics to address disparities in telehealth access. The effectiveness of this approach will be assessed over 24 months through clinical outcomes such as glycosylated hemoglobin levels.
Why it matters
Potential benefit: If successful, this intervention could significantly improve chronic disease management and health outcomes for low-income patients.
How similar studies have gone: Other studies have shown promise in using digital health interventions to improve chronic disease management, suggesting this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥ 18 years of age * English or Spanish-Speaking * Have uncontrolled diabetes defined as a listed diagnosis of diabetes with a recorded A1C ≥ 8.0% in the past two years or have uncontrolled HTN defined as a listed diagnosis of HTN and last recorded documented SBP \>140 mmHg * At least 2 visits at a participating SFHN primary care site in the last 24 months Exclusion Criteria: * Higher than average digital literacy, defined as an Digital Healthcare Literacy Scale (DHLS) score greater than 10, as determined prior to the baseline study visit; these patients may not benefit from a digital coaching intervention. * Presence of co-morbid conditions that would make it inappropriate to focus on telehealth chronic disease management. Conditions may include: end-stage or terminal condition with limited life expectancy and severe mental illness. * Lack of any working phone number * Visual or hearing impairment that precludes use of telehealth for chronic disease management * Cognitive impairment defined by the inability to restate study goals during the consent process * Pregnant
Where it's running
-
Zuckerberg San Francisco General Hospital (ZSFG) & SF Department of Public Health (DPH)
San Francisco, California, United States Recruiting
Study contacts
- Principal investigator: Delphine Tuot, MD MAS — University of California, San Francisco
- Study coordinator: Andy Ramirez, BS
- Email: Andy.Ramirez@ucsf.edu
- Phone: 415-562-4509
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
New virtual care pathway for older adults with chronic diseases
A teleconsultation-based care pathway for adults 60+ with hypertension, diabetes, or dyslipidemia to see if it’s feasible and cost-saving in Malaysian primary care compared with usual clinic visits.
-
Benefits of Retained Insulin for Good Health in Diabetes
This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.
-
Improving Care for underserved older Black patients with cardiovascular and other chronic conditions
This study tests a culturally tailored approach to patient-centered care for older African American patients with cardiovascular disease and other conditions who receive care at a community hospital.
-
Myokines in metabolic and endocrine diseases linked to sarcopenia
This study tests whether myokines can serve as biomarkers or drivers of sarcopenia and sarcopenic obesity in people with metabolic or endocrine diseases.
-
Miniature breath sensors to detect hypo- and hyperglycemia in young people with diabetes
A small breath-sensor device will try to see if specific breath compounds can signal low or high blood sugar in youths with diabetes.
-
Polypill Approach for Multiple Cardiovascular Risk Factors
Researchers are testing a fixed-dose pill strategy to help people aged 50–75 with high blood pressure, high cholesterol, and diabetes see if it lowers their heart-disease risk and reduces future events.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.